PURE Bioscience Reports Increased Sales and Leadership Changes Amid Financial Losses
Trendline

PURE Bioscience Reports Increased Sales and Leadership Changes Amid Financial Losses

What's Happening? PURE Bioscience, Inc., a company known for its non-toxic silver dihydrogen citrate (SDC) antimicrobial, has released its financial results for the fiscal third quarter ending April 30, 2026. The company reported net product sales of $506,000, a slight increase from the previous yea
AI Generated
This may include content generated using AI tools. Glance teams are making active and commercially reasonable efforts to moderate all AI generated content. Glance moderation processes are improving however our processes are carried out on a best-effort basis and may not be exhaustive in nature. Glance encourage our users to consume the content judiciously and rely on their own research for accuracy of facts. Glance maintains that all AI generated content here is for entertainment purposes only.